Сохранение фертильности больным злокачественными и пограничными опухолями яичников
pdf

Ключевые слова

онкофертильность
рак яичников
пограничные опухоли яичников
контролируемая стимуляция яичников
методы вспомогательных репродуктивных технологий
криоконсервация

Аннотация

Имеющиеся в настоящее время данные о сохранения фертильности у пациенток с ранними стадиями рака яичников указывают на онкологическую безопасность и высокую эффективность как органосохраняющих операций, так и методов вспомогательных репродуктивных технологий. Международное научное сообщество все чаще обсуждает важность своевременного информирования пациентов и реализации стратегий, направленных на сохранение репродуктивной функции у данной категории больных. Принимая во внимание ограниченное количество наблюдений, исследования о возможных видах сохранения фертильности пациенткам со злокачественными опухолями яичников должны продолжаться.

https://doi.org/10.37469/0507-3758-2021-67-4-547-553
pdf

Библиографические ссылки

Lambertini M, Del Mastro L, Pescio MC et al. Cancer and fertility preservation: international recommendations from an expert meeting // BMC Med. 2016 Jan 4;14:1. https: // doi: 10.1186/s12916-015-0545-7. PMID: 26728489; PMCID: PMC4700580

Stewart C, Ralyea C, Lockwood S. Ovarian Cancer: An Integrated Review // Semin Oncol Nurs. 2019;35(2):151-156. https: // doi: 10.1016/j.soncn.2019.02.001. Epub 2019 Mar 11. PMID: 30867104

Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2018;68(6):394-424. https: // doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593

du Bois A, Reuss A, Pujade-Lauraine E et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) // Cancer. 2009 Mar 15;115(6):1234-44. https: // doi: 10.1002/cncr.24149. PMID: 19189349.

Torre LA, Trabert B, DeSantis CE et al. Ovarian cancer statistics, 2018 // CA Cancer J Clin. 2018 Jul;68(4):284-296. https: // doi: 10.3322/caac.21456. Epub 2018 May 29. PMID: 29809280; PMCID: PMC6621554

Park JY, Kim DY, Suh DS et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes // Gynecol Oncol. 2008;110(3):345-53. https: // doi: 10.1016/j.ygyno.2008.04.040. Epub 2008 Jun 30. PMID: 18586310

Wright JD, Shah M, Mathew L et al. Fertility preservation in young women with epithelial ovarian cancer // Cancer. 2009;115(18):4118-26. https: // doi: 10.1002/cncr.24461. PMID: 19670446

Pérez-Quintanilla M, Del Real-Ordoñez S, Gallardo-Alvarado L, Cantu-de Leon D. Fertility-sparing treatment for epithelial ovarian cancer: a literature review // Chin Clin Oncol. 2020;9(4):48. https: // doi: 10.21037/cco-20-38. Epub 2020 Jul 14. PMID: 32692186

Fruscio R, Corso S, Ceppi L et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series // Ann Oncol. 2013;24(1):138-44. https: // doi: 10.1093/annonc/mds241. Epub 2012 Sep 3. PMID: 22945381

Практические рекомендации RUSSCO/ 2020;10(3s2):192.

Colombo N, Sessa C, du Bois A et al. ESMO-ESGO Ovarian Cancer Consensus Conference Working Group. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease† // Ann Oncol. 201;30(5):672-705. https: // doi: 10.1093/annonc/mdz062. PMID: 31046081

Feichtinger M, Rodriguez-Wallberg KA. Fertility preservation in women with cervical, endometrial or ovarian cancers // Gynecol Oncol Res Pract. 2016;3:8. https: // doi: 10.1186/s40661-016-0029-2. PMID: 27468354; PMCID: PMC4962474

Trimbos B, Timmers P, Pecorelli S et al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial // J Natl Cancer Inst. 2010;102(13):982-7. https: // doi: 10.1093/jnci/djq149. Epub 2010 May 5. PMID: 20445161; PMCID: PMC2911043

Park JY, Heo EJ, Lee JW et al. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer // J Gynecol Oncol. 2016;27(2):e20. https: // doi: 10.3802/jgo.2016.27.e20. PMID: 26768783; PMCID: PMC4717225

Bentivegna E, Fruscio R, Roussin S et al. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients // Fertil Steril. 2015;104(5):1319-24. https: // doi: 10.1016/j.fertnstert.2015.06.008. Epub 2015 Jul 3. PMID: 26149354

Schlaerth AC, Chi DS, Poynor EA et al. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer // Int J Gynecol Cancer. 2009;19(7):1199-204. https: // doi: 10.1111/IGC.0b013e31819d82c3. PMID: 19823055

Kwon YS, Hahn HS, Kim TJ et al. Fertility preservation in patients with early epithelial ovarian cancer // J Gynecol Oncol. 2009;20(1):44-7. https: // doi: 10.3802/jgo.2009.20.1.44. Epub 2009 Mar 31. PMID: 19471664; PMCID: PMC2676494

Zapardiel I, Diestro MD, Aletti G. Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes // Eur J Surg Oncol. 2014;40(4):387-93. https: // doi: 10.1016/j.ejso.2013.11.028. Epub 2013 Dec 13. PMID: 24368049

Бахидзе Е.В. Фертильность, беременность и гинекологический рак. СПб: Издательство ДИЛЯ, 2004:288.

Schilder JM, Thompson AM, DePriest PD et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy // Gynecol Oncol. 2002;87(1):1-7. https: // doi: 10.1006/gyno.2002.6805. PMID: 12468335

Smith HO, Berwick M, Verschraegen CF et al. Incidence and survival rates for female malignant germ cell tumors // Obstet Gynecol. 2006;107(5):1075-85. https: // doi: 10.1097/01.AOG.0000216004.22588.ce. PMID: 16648414

Ertas IE, Taskin S, Goklu R et al. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors // J Obstet Gynaecol Res. 2014;40(3):797-805. https: // doi: 10.1111/jog.12253. Epub 2013 Dec 10. PMID: 24320102

Zapardiel I, Cruz M, Diestro MD et al. Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers // Hum Reprod Update. 2016;22(3):281-305. https: // doi: 10.1093/humupd/dmv066. Epub 2016 Jan 12. PMID: 26759231

Schüring AN, Fehm T, Behringer K et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation // Arch Gynecol Obstet. 2018;297(1):241-255. https: // doi: 10.1007/s00404-017-4594-3. Epub 2017 Nov 24. PMID: 29177593; PMCID: PMC5762797

Daraï E, Fauvet R, Uzan C et al. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options // Hum Reprod Update. 2013;19(2):151-66. https: // doi: 10.1093/humupd/dms047. Epub 2012 Dec 12. PMID: 23242913

Maramai M, Barra F, Menada MV et al. Borderline ovarian tumours: management in the era of fertility-sparing surgery // E cancer medical science. 2020;14:1031. https: // doi: 10.3332/ecancer.2020.1031. PMID: 32419843; PMCID: PMC7221127

Vasconcelos I, de Sousa Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk // Eur J Cancer. 2015;51(5):620-31. https: // doi: 10.1016/j.ejca.2015.01.004. Epub 2015 Feb 3. PMID: 25661104

Helpman L, Beiner ME, Aviel-Ronen S et al. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors // Fertil Steril. 2015;104(1):138-44. https: // doi: 10.1016/j.fertnstert.2015.03.038. Epub 2015 May 5. PMID: 25956371

Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N. Successful Oocyte Cryopreservation in Reproductive-Aged Cancer Survivors // Obstet Gynecol. 2016;127(3):474-480. https: // doi: 10.1097/AOG.0000000000001248. PMID: 26855092

Мустафин Р.Н., Халикова Л.В., Хуснутдинова Э.К. Особенности метастазирования рака яичника // Креативная хирургия и онкология. 2020;10(4):319-329. https://doi.org/10.24060/2076-3093-2020-10-4-319-329

Chitrathara K, Sheikh ZA, Vijaykumar DK et al. Is hysterectomy needed in ovarian cancer? // Indian J Cancer. 2011;48(4):471-6. https: // doi: 10.4103/0019-509X.92259. PMID: 22293263

Armstrong DK, Alvarez RD, Bakkum-Gamez JN et al. NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019 // J Natl Compr Canc Netw. 2019;17(8):896-909. https: // doi: 10.6004/jnccn.2019.0039. PMID: 31390583

Cakmak H, Rosen MP. Ovarian stimulation in cancer patients // Fertil Steril. 2013;99(6):1476-84. https: // doi: 10.1016/j.fertnstert.2013.03.029. PMID: 23635348

ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D'Angelo A, Chuva de Sousa Lopes SM, Demeestere I, Dwek S, Frith L, Lambertini M, Maslin C, Moura-Ramos M, Nogueira D, Rodriguez-Wallberg K, Vermeulen N. ESHRE guideline: female fertility preservation // Hum Reprod Open. 2020;2020(4):hoaa052. https: // doi: 10.1093/hropen/hoaa052. PMID: 33225079; PMCID: PMC7666361

Назаренко Т.В. Вспомогательная репродукция в клинической практике. Разбор клинических случаев с использованием международных и отечественных рекомендаций. М.: МедКом-Про, 2020.

Рой Хомбург. Стимуляция яичников: практическое руководство. Пер. c англ. / Под ред. И.Ю. Когана, М.: ГЭОТАР-Медиа, 2019.

Matthews ML, Hurst BS, Marshburn PB et al. Cancer, fertility preservation, and future pregnancy: a comprehensive review // Obstet Gynecol Int. 2012;2012:953937. https: // doi: 10.1155/2012/953937. Epub 2012 Mar 18. PMID: 22529860; PMCID: PMC3316966

Ichinose M, Fujimoto A, Osuga Y et al. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia // Int J Gynecol Cancer. 2013;23(2):288-93. https: // doi: 10.1097/IGC.0b013e31827c18a1. PMID: 23314282

Akel RA, Guo XM, Moravek MB et al. Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer // J Adolesc Young Adult Oncol. 2020;9(3):367-374. https: // doi: 10.1089/jayao.2019.0124. Epub 2020 Jan 10. PMID: 31923372; PMCID: PMC7307696

Tourgeman DE, Lu JJ, Boostanfar R et al. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro // Fertil Steril. 2002;78(5):1096-9. https: // doi: 10.1016/s0015-0282(02)03367-8. PMID: 12414000

Basille C, Olivennes F, Le Calvez J et al. Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours // Hum Reprod. 2006;21(12):3241-5. https: // doi: 10.1093/humrep/del301. Epub 2006 Aug 7. PMID: 16893916

Mangili G, Somigliana E, Giorgione V et al. Fertility preservation in women with borderline ovarian tumours // Cancer Treat Rev. 2016;49:13-24. https: // doi: 10.1016/j.ctrv.2016.06.010. Epub 2016 Jul 7. PMID: 27428850

Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility // Cochrane Database Syst Rev. 2013 Aug 13;2013(8):CD008215. https: // doi: 10.1002/14651858.CD008215.pub2. Update in: Cochrane Database Syst Rev. 2019 Jun 18;6:CD008215. PMID: 23943232; PMCID: PMC6457641

Schattman GL. CLINICAL PRACTICE. Cryopreservation of Oocytes // N Engl J Med. 2015;373(18):1755-60. https: // doi: 10.1056/NEJMcp1307341. PMID: 26510023

Mandelbaum RS, Klar M, Takiuchi T et al. Fertility-sparing treatment for early-stage epithelial ovarian cancer: Contemporary oncologic, reproductive and endocrinologic perspectives // J Obstet Gynaecol Res. 2020;46(8):1263-1281. https: // doi: 10.1111/jog.14302. Epub 2020 Jun 4. PMID: 32500605

Abir R, Ben-Aharon I, Garor R et al. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy // Hum Reprod. 2016;31(4):750-62. https: // doi: 10.1093/humrep/dew007. Epub 2016 Feb 4. PMID: 26848188

Brambillasca F, Guglielmo MC, Coticchio G et al. The current challenges to efficient immature oocyte cryopreservation // J Assist Reprod Genet. 2013;30(12):1531-9. https: // doi: 10.1007/s10815-013-0112-0. Epub 2013 Oct 10. PMID: 24114631; PMCID: PMC3843180

Son WY, Henderson S, Cohen Y et al. Immature Oocyte for Fertility Preservation // Front Endocrinol (Lausanne). 2019;10:464. https: // doi: 10.3389/fendo.2019.00464. PMID: 31379739; PMCID: PMC6650526

Letourneau JM, Ebbel EE, Katz PP et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer // Cancer. 2012;118(6):1710-7. https: // doi: 10.1002/cncr.26459. Epub 2011 Sep 1. PMID: 21887678; PMCID: PMC3235264

Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

Copyright (c) 2021 Ольга Лавринович, Мария Яковлева, Игорь Берлев, Адель Урманчеева